LambdaVision Company
LambdaVision is a biotechnology company focused on developing a protein-based artificial retina designed to restore meaningful vision for patients affected by retinal degenerative diseases. The technology uses the light-activated protein bacteriorhodopsin layered alternately with polymers onto a flexible, ion-permeable membrane in a thin-film structure that mimics the function of photoreceptor cells. LambdaVision is also leveraging microgravity manufacturing—via flights to the International Space Station (ISS) and low-Earth orbit (LEO) environments—to enhance the homogeneity, stability, and optical quality of its artificial retina membranes.
Founded Date:
2009-01-01
Last Funding Date:
2025-11-05
Industry:
Quantum Biology
Total Funding:
13727008
Headquarters:
Farmington,Connecticut,United States,North America
Funding Status:
private
Super Industry:
Quantum Sensing
Funding Stage:
Seed
Funding Total Value:
13727008
Last Funding Total Usd:
7000000
Last Funding Total Currency:
USD
Last Funding Total Value:
7000000
Founders:
Robert Birge
Phone Number:
+1 860-679-2558